Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diclofenac 1% gel trial versus Voltaren Emulgel and placebo for acute traumatic musculoskeletal inflammation
2015-001779-29Phase 3Completed
- Sponsor
- Epifarma
- Start
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of diclofenac in musculoskeletal injuries and musculoskeletal inflammation (3 arms), sponsored by Epifarma. Primary endpoint: Change from baseline in pain at rest. Started Oct 2016; status: completed.
02
Drugs
diclofenac
03
Conditions
musculoskeletal injuriesmusculoskeletal inflammation
Beyond the preview
Go deeper on 2015-001779-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001779-29.